Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
ABBOTT LABORATORIES
ABT
Healthcare
Medical Devices
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the...
international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSE:ABT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 13, 2022 11:00am
New Press Release - Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Abbott Laboratories (ABT) Investors of Class Action and to Actively Participate
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Abbott Laboratories (“Abbott” or “the Company”) (NYSE: ABT) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 13, 2022 10:18am
New Press Release - Abbott Laboratories Stock: Abbott Shareholders Are Encouraged to Contact Kehoe Law Firm, P.C. to Discuss Potential Legal Claims
New York, New York--(Newsfile Corp. - September 13, 2022) - Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Abbott Laboratories ("Abbott") (NYSE: ABT) breached their fiduciary duties to Abbott and its shareholders.The investigation concerns whether members of...
read article.
IAMGOLD Publishes 17th Annual Sustainability Report and Inaugural Tailings Management Report
posted May 17, 2024 9:00am by
IAMGOLD Corp
-
|
"IAMGOLD is dedicated to fostering sustainable practices that benefit communities, minimize environmental impacts, and uphold the highest standards of business integrity," said Renaud Adams, President and Chief Executive Officer of IAMGOLD. "The 2023 Sustainability Report marks the 17th year of annual reporting for IAMGOLD on the sustainability topics that are most material to our stakeholders and ...read more
(0)
•••
johnson021
X
View Profile
View Bullboard History
Post by
johnson021
on Sep 13, 2022 8:32am
Guidewires Market Share, Size, Growth and Report 2022-2027
According to IMARC Group’s latest report, titled “Guidewires Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027, " Offers a comprehensive analysis of the industry
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 13, 2022 7:15am
New Press Release - ABT LAWSUIT FILED: Jakubowitz Law Pursues Claims on Behalf of ABBOTT LABORATORIES Shareholders
New York, New York--(Newsfile Corp. - September 13, 2022) - Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Abbott Laboratories (NYSE: ABT).CLICK HERE FOR MORE DETAILS:https://claimyourloss.com/securities/abbott-laboratories-loss...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 13, 2022 5:46am
New Press Release - ABT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 31, 2022 in the Class Action Filed on Behalf of Abbott Laboratories Shareholders
NEW YORK, Sept. 13, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Abbott Laboratories (NYSE: ABT) alleging that the Company violated federal securities laws.This lawsuit is on behalf of all persons or entities who...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 13, 2022 1:21am
New Press Release - INVESTOR NOTICE: Abbott Laboratories Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ABT
San Diego, California--(Newsfile Corp. - September 13, 2022) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Abbott Laboratories (NYSE: ABT) common stock between February 19, 2021 to June 8, 2022, both dates inclusive (the "Class Period") have until...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 12, 2022 7:16pm
New Press Release - SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Abbott Laboratories of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 31, 2022 - (ABT)
New York, New York--(Newsfile Corp. - September 12, 2022) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Abbott Laboratories (NYSE: ABT).Shareholders who purchased shares of ABT during the class period listed are encouraged to...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 12, 2022 5:48pm
New Press Release - Abbott Laboratories Deadline Alert
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Abbott Laboratories To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - September 12, 2022) - Faruqi & Faruqi, LLP, a leading national securities law...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 12, 2022 3:12pm
New Press Release - ABT LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Abbott Laboratories
New York, New York--(Newsfile Corp. - September 12, 2022) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Abbott Laboratories ("Abbott") (NYSE: ABT) . This lawsuit is on behalf of all persons or entities who...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 12, 2022 2:26pm
New Press Release - ABT INVESTOR NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Abbott Laboratories Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABT
NEW YORK, Sept. 12, 2022 /PRNewswire/ --WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Abbott Laboratories (NYSE: ABT) between February 19, 2021 and June 8, 2022, both dates inclusive (the "Class Period"), of the important October 31, 2022 lead...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 12, 2022 1:02pm
New Press Release - SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 12, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Abbott Laboratories ("Abbott" or "the Company") (NYSE:ABT) for violations of §§10(b) and 20(a) of the Securities Exchange Act...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 12, 2022 11:58am
New Press Release - ABT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 31, 2022 in the Class Action Filed on Behalf of Abbott Laboratories Limited Shareholders
New York, New York--(Newsfile Corp. - September 12, 2022) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Abbott Laboratories (NYSE: ABT) alleging that the Company violated federal securities laws.This lawsuit is on behalf of all persons or...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 12, 2022 9:20am
New Press Release - SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Abbott Laboratories with Losses of $100,000 to Contact the Firm
Los Angeles, California--(Newsfile Corp. - September 12, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Abbott Laboratories ("Abbott" or "the Company") (NYSE: ABT) for violations of §§10(b) and 20(a) of the...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 12, 2022 7:07am
New Press Release - Abbott Class Action: Levi & Korsinsky Reminds Abbott Laboratories Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 31, 2022 - ABT
New York, New York--(Newsfile Corp. - September 12, 2022) - Levi & Korsinsky, LLP notifies investors in Abbott Laboratories ("Abbott" or the "Company") (NYSE: ABT) of a class action securities lawsuit.The lawsuit on behalf of Abbott investors has been commenced in the the United States District...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 12, 2022 5:46am
New Press Release - CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Abbott Investors of a Lead Plaintiff Deadline of October 31, 2022
NEW YORK, Sept. 12, 2022 /PRNewswire/ -- Attention Abbott Laboratories ("Abbott") (NYSE: ABT) shareholders:The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors. This lawsuit is on behalf of all persons or entities who purchased or otherwise...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project